Ranalexin

Ranalexin, an antimicrobial peptide, demonstrates inhibition of S. aureus, E. coli, and P. aeruginosa, with respective minimum inhibitory concentrations (MICs) of 4, 32, and 128 ?g/mL [1].

C([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC(CNC(CNC([C@@H](NC([C@H](CC1=CC=CC=C1)N)=O)CC(C)C)=O)=O)=O)CC(C)C)=O)[C@H](CC)C)=O)CCCCN)=O)[C@H](CC)C)=O)[C@@H](C)C)(=O)N2[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H]3C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](C)C)C(=O)N[C@@]([C@@H](C)O)(C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CSSC3)[H])=O)[C@H](CC)C)=O)CCSC)=O)C)=O)CCC2